Brief: Bioceltix Says EGM To Vote On Increase of Share Capital Via Issue Of O Series Shares
20/10/2025 06:53
Oct 20 (Reuters) - Bioceltix SA BCXP.WA: SAID ON FRIDAY EGM TO VOTE ON INCREASE OF SHARE CAPITAL BY 15,000 ZLOTYS VIA ISSUE OF O SERIES SHARES NEW SHARES TO BE OFFERED TO KVARKO GROUP IN A PRIVATE SUBSCRIPTION ISSUE PRICE SET AT 87.00 ZLOTYS PER SHARE THE ISSUE IS PART OF AN INVESTMENT DEAL WITH KVARKO GROUP EXTRAORDINARY GENERAL MEETING TO BE HELD ON NOV 17 Source text for Workspace: nEM6ygqw4a Further company coverage: BCXP.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bioceltix SA
See all newsBrief: Bioceltix Signs 2 Mln Zlotys Net Deal With Intero For Construction Works
Brief: Bioceltix Receives Permit For Biological Veterinary Drugs Facility
Brief: Bioceltix Veterinary Biological Drug Project InnoBioVet Recommended For 15.1 Million Zloty Subsidy
Brief: Bioceltix Signs Advisory Agreement For FDA Regulatory Support
Brief: Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility